HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 3,502.675 million compared to CNY 3,937.272 million a year ago. Operating income was CNY 110.460 million compared to CNY 189.519 million a year ago. Net income was CNY 80.655 million compared to CNY 140.559 million a year ago. Basic earnings per share from continuing operations was CNY 0.1391 compared to CNY 0.2424 a year ago.